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a-Synuclein, a presynaptic protein of the central 
nervous system, has been implicated in the synaptic 
events such as neuronal plasticity during development 
and learning, and neuronal degeneration under 
pathological conditions. As an effort to understand the 
biological function of ex-synuclein, we examined the 
expression patterns of ex-synuclein in various human 
hematopoietic cells, and in Drosophila at different 
developmental stages. The ex-synuclein was 
ubiquitously expressed in all the tested hematopoietic 
cells including T cells, B cells, NK cells, and monocytes, 
as well as in the lymphoma cell lines, Jurkat and KS62. 
A potential ex-synuclein homologue was also expressed 
in Drosophila, and its expression appeared to be 
temporally and spatially regulated during development. 
Our data suggest that ex-synuclein may function in 
invertebrates as well as in vertebrates and its function 
may not be restricted to the neuron. 
Keywords: Development; Gene Expression; NACP; 
Neurodegenerative Disease; Synuclein. 
Introduction 
ex-Synuclein, also known as the precursor protein of the 
non-A~ component of Alzheimer's disease amyloid 
(NACP), is a presynaptic protein of unknown function 
composed of 140 amino acid residues (Iwai et ai., 1995; 
Jakes et ai., 1994; Veda et al., 1993). Synuclein was first 
identified in electric fish (Maroteaux et ai., 1988), and 
subsequently identified in rat (Maroteaux and Scheller, 
1991 ; Shibayama-Imazu et aI., 1993; Tobe et aI., 1992), 
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bovine (Nakajo et aI. , 1990; 1993), human (Jakes et al. , 
1994; Veda et ai., 1993), and canary bird (George et aI. , 
1995). The synuclein protein has a sequence that has been 
highly conserved among birds, fish , and mammals. ex-
Synuclein is expressed primarily in the nervous system, 
where it is concentrated in presynaptic nerve terminals 
(Irizarry et al. , 1996; Iwai et al. , 1995; Jakes et aI. , 1994; 
Veda et at., 1993). However, it is also expressed in other 
tissues including the heart, skeletal muscle, pancreas, and 
placenta, though less abundantly than in the brain (Jakes et 
ai. , 1994; Veda et ai. , 1993; 1994). The physiological 
function of ex-synuclein is not clear, but the predominant 
localization of the protein at presynaptic nerve terminals 
(Irizarry et al. , 1996; Iwa'i et aI., 1995; Jakes et al., 1994; 
Veda et al., 1993) suggests that it may playa critical role 
in synaptic events, such as neuronal plasticity during 
development (Withers et ai. , 1997) and learning (George et 
ai., 1995), and degeneration of nerve terminals under 
pathological conditions in Alzheimer 's disease (Brooks et 
al., 1994; Veda et ai., 1993) and Parkinson's di sease 
(Polymeropoulos et ai. , 1997; Spillantini et ai. , 1998). 
To better understand the biological function of ex-
synllclein, we examined the expression patterns of ex-
synuclein in various human hematopoietic cells, and in an 
invertebrate sys tem , Drosop hila , at different 
developmental stages. We demon strate here that ex-
synuclein is ubiquitously expressed in hematopoietic cells 
including T cells, B cells, NK cells, and monocytes, as well 
as in the lymphoma cell lines, Jurkat and K562. We also 
show that a potential ex-synuclein homologue is expressed 
in Drosophila, and the expression of the protein appears to 
be differentially regulated during development. 
Abbreviation s: NACP, non-A~ co mponent of Al zheimer 's 
disease; NK cells, natural killer cells; PBMC, peripheral blood 
mononuclear cell. 
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Materials and Methods 
Separation of T cells, B cells, NK cells, and monocytes from 
PBMCs Peripheral blood mononuclear cell s (PBMCs) were 
puri fied by Fico ll-Hypaqu e (Pharmacia, Uppsala, Sweden) 
de nsity gradi e nt centri fugati on from 5 ml of heparini zed 
peripheral blood donated by a healthy volunteer. T cells, B cells, 
NK cell s, and monocy tes were iso lated from PBMCs by 
immunomagnetic beads (Dynal, Great Neck, NY). Briefl y, 
PBM Cs were was hed a nd res uspe nd ed in RPMI 1640 
supplemented with I % fe tal bovine serum at a concentration of 
2-3 X 106 cell s/ml. Pos itive selecti on for monocytes was 
perfo rm ed by inc ub atin g PBMCs with a nti- C D 14 
immunomagnetic beads fo r 30 min at 4°C on a rotating shaker. 
The unb o und ce ll s were th e n in cub ated with a nti -CD3 
immunomagnetic beads for T cell separation. Subsequentl y, B 
cells were separated from the unbound cells with anti-CD 19 
immunomagnetic beads. In the remai ning cell s, characterization 
of the surface marker was performed by fl ow cytometry analysis . 
Mo re th an 90 % of these ce ll s were C D3 - CD 16 + or 
CD3- CD56+, and these cells were considered as NK cells. 
RT-PCR analysis Total RNA was isol ated from purifi ed 
hematopoietic cells by acid guanidium isothiocyanate-phenol-
chloroform extraction. The fi rst strand cDNA was synthesized by 
using 1- 5 Ilg of RNA , 0. 1 0 .0 . unit of random hexamer 
(Pharmacia, Uppsala, Sweden), and 600 units of MLV reverse 
transcriptase (Gibco BRL, Gaithersburg, MD) in a total volume 
of 100 Ill. The reaction mixture was incubated fo r I h at 42°C and 
used fo r PCR. The N-terminal part of a-synuclein (307 bp) was 
amplified by PCR using 5 III of cDNA and Taq DNA polymerase 
with the primer set, Nl and C l , and the C-terminal part of a -
synuclein (179 bp) was amplified with the primer set, N2 and C2 
(Fig. lA). The complete protein-coding region of a -synuclein 
(445 bp) was a lso ampli fied by PCR using Nl and C2 
oligonucleotide primers. Simi lar primer sets were designed and 
used fo r the amplificati on of ~-sy nu c l e in cDNA, and the 
sequ e nces of th e prime rs were GCCAGGATGGACGT-
GTTCATG (PN l ), GGCTGCTGCGATGTTCCCTGC (~C I ) , 
GCCTCAC ATCTGGGAGGAGCT (PN2), and CCCCTA-
CGCCTCTGGCTCATA (~C2) , respecti vely. 
Purification and antibody production of a -synuclein a-
Synuclein was overexpressed in E. coli and the recombinant 
protein was purified as previously described (Jakes et ai., 1994 ; 
Kim , 1997; Paik et ai. , 1997). Polyclonal antibody was raised 
against the purified recombinant protein . Briefl y, a-synuclein 
(500 !Lg) was mi xed at a I : I ratio with Freund's complete 
adjuvant (Sigma, Saint Louis, MO) and used to immunize a white 
Dutch rabbit. A booster injection was given three weeks after the 
primary immunization using 250 !Lg of protein mixed at a I: 1 
ratio with Freund 's incomplete adjuvant (Sigma) . Another booster 
inj ection was given after an additional three weeks, and the 
animal was bled two weeks later. 
Western blot analysis Cell Iysates were resolved on 12% SDS 
acrylamide gels, and the proteins were transferred onto PVDF 
membranes. Western blot analys is was perfo rmed with the 
polyclonal anti-a -synuclein antibody. The blots were developed 
using secondary horseradish peroxidase-conjugated sheep anti-
rabbit IgG antibody (Amersham, Buckinghamshire, England) and 
ECL substrate (Amersham). 
Temporal and spatial expression patterns of Drosophila a -
synuclein The embryos fi xed with formaldehyde/glutaraldehyde 
were rehydrated with BBT (PBS containing 0. 1% Tween-20, 
0.1 % BSA) and blocked with BBS (BBT containing 2% serum) 
for 40 min . Then they were washed with BBT and incubated with 
purified anti-a-synuclein antibody overnight at 4°C. The embryos 
were again washed with BBT and blocked with BBS. They were 
incubated with biotinylated secondary antibody (ABC kit, Vector 
Laboratories, CA) fo r 2 h at room temperature, then washed with 
PBT (PBS containing 0.1 % Tween-20). They were then incubated 
with the A + B mix (Vector Laboratory) fo r 1 h at room 
temperature, and washed with PBT. Finally, the embryos were 
stained by incubating in peroxidase substrate solution containing 
DAB (DAB 0.5 mg/ml, 0.01 5% HP 2 in PBT) and mounted with 
Permount (Fisher, PA) . 
Results and Discussion 
To investi gate the expression of a-synuclein and ~­
synuclein in hematopoietic cell s, RT-PCR was caITied out 
usin g cDNAs obta ined f rom ph eriph e ra l bl ood 
mononuclear cells (PBMCs). Two pairs of oligonucleotide 
primers were designed to amplify the N- and C-terminal 
part s of a-sy nuc le in (Fi g. l A) . RT-PCR ana lys is 
demonstrated that significant amounts of a-synuclein 
mRNA was present in PBMCs. Similar RT-PCR analysis 
was canied out for ~-synuclein with ~-synuclein-specific 
oli gonucleotide primers, but the ampli fication of ~­
synuclein cDNA was not observed (Fig. IB), suggesting 
that the ~-synuclein was not expressed in PBMCs. We next 
investigated the cell type expression of a-synuclein in 
hematopoietic cells. PBMCs were further fractionated into 
T cell s, B cells, NK cell s, and monocyt"es, and RT-PCR 
analysis was performed using cDNAs obtained from these 
cell s. Fi gure 2 shows that a- sy nu c lein mRNA is 
ubiquitously expressed in all the tested hematopoietic cells 
including T cell s, B cells, NK cells, and monocytes . 
However, ~-synuclein was not detected in any of the 
hematopoieti c cells by RT-PCR analysis (data not shown). 
These results suggest that the expressions of a-synuclein 
and ~-synuc l ein are differentially regulated in human 
tissues. 
We also investigated whether a-synuclein protein was 
expressed in hematopoietic cell s. Western blot analysis 
with polyclonal antibody against the recombinant a-
synuclein revealed that two major protein bands (37 kDa 
and 19 kDa) were strongly reactive to the antibody 
(Fig. 3A). The 37 kDa protein is an unidentified protein 
which is cross-reactive against anti-a-synuclein antibodies 
(Hashimoto et al., 1997; Ueda et aI. , 1993). Bacterially 
expressed a-synuclein protein almost co-migrated with the 
19 kDa protein. The slight difference in mobility may 
indicate that a-synuclein is posttranslationally modified in 
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Fig. 1. a-Synuclein primer sets and RT-PCR analysis. A. a-synuclein primer sets for RT-PCR. Primer set N lICl amplifies the N-terminal 
part (307 bp), 2/C2 ampl ifies the C-terminal part ( 179 bp), and N lIC2 amplifies whole cDNA of a-synuclein (445 bp). Similar primer 
sets were used for ~-synuc l e in as described in Materials and Methods. B. Expression of a- and ~-synuclein in PBMCs. RT-PCR analysis 
shows that a-synuclein is expressed in PBMCs, but ~-synucl ein is not. Recombinant DNAs of a - and ~-synuc l ein were used as positive 
controls. 
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Fig. 2. Ubiquitous expression of a -synuclein in immune cells. 
RT-PCR analysis shows that a-synuclein is expressed in T cell s, 
B cells, NK cell s, and monocytes. As described in Fig. 1, primer 
set N lIC I amplifies the N-terminal part, N2/C2 amplifies the C-
terminal part, and NlIC2 amplifies whole cDNA of synuclein. 
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PBMCs, as has been observed in brain cell s (Jakes et at., 
1994). In addition, previous works have shown that a-
synuclein runs slightly faster than ~-synuclein on SDS-
PAGE (Jakes et at., 1994). Taken together, these results 
indicate that the 19 kDa protein is a-synuclein. In some 
PBMCs, the alternatively spliced form of a-synuclein 
(NACP1l2 composed of 112 amino acids, 14 kDa) was 
also detected (Fig. 3A, PBMC4). The a-synuclein was also 
detected in two leukemia cell lines, lurkat and K562 (Fig. 
3B). Expression of a-synuclein in K562 ce ll s has 
previously been described (Hashimoto et at., 1997) . 
Using the anti-a-synuclein antibody, we fo und that a 19 
kDa protein is also present in adult bodies and embryos of 
Drosophila (Fig. 3C). Interestingly, the band intensity of 
the 19 kDa protein was weaker in embryos, suggesting that 
the expression of the protein is developmentally regu lated. 
This was further supported by the fact that the potential 
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Fig. 3. Western blot analysis of a-synuclein . About 200 Ilg of total cell proteins were loaded into each lane, and 0.1 Ilg of recombinant 
a-synuclein was used as a positive control. A. Western blot analysis indicates that a -synuclein ( l9 kDa) is expressed in PBMCs. The 
37 kDa band represents a unidentified protein which is cross-reactive against anti-a-synuclein antibodies (Hashimoto et al., 1997 ; Veda 
et aI. , 1993). B. Expression of a -synuclein in the lymphoma cell lines, lurkat and K562. C. A potential a-synuclein homologue (19 kDa) 
is also expressed in Drosophila. The l4 kDa band in (A) and (C) may represent an alternati ve splicing form of a-synuclein (NACP1 l2) 
composed of the N-terminal 11 2 amino acids. 
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Control Synuclein 
Fig. 4. Temporal and spatial expression patterns of Drosophila synuclein homologue. Control embryos were initially treated with bovine 
serum albumin and allowed to bind biotin-labelled secondary an tibody. Embryos marked with synuclein were immunostained by 
treatment with primary synuclein antibody and biotin-labelled secondary antibody. Panels: 1, embryos at stage 2; 2, embryos at stage 
5; 3, embryos at stage 7; 4, embryos at stage 10; and 5, embryos at stage 13. (Stages are determined according to Campos-Ortega and 
Hartenstein, 1985) . 
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NACPl12 homologue (an alternatively spliced form of cx-
synucl ei n, 14 kDa) was onl y detected in Drosophila 
embryos, but not in adult bodies (Fig. 3C). It is intriguing 
to note that NACP1l2 is only found in fetal tissues, while 
the full- length cx-synuclein was found in all human ti ssues 
examined (Ueda et al., 1994). Similar phenomena have 
been observed in a rat and canary bird. The expression of 
a synuclein homologue in a rat, phosphoneuroprotein 14 
(PNP14), increased during the first month of the neonatal 
period (Shibayama-Imazu et al., 1993), and the canary 
homologue, synelfi n, was locally upregulated in the song 
control circuit during a critical period for song learning 
(George et al., 1995). In addition , Hashimoto et al. (1997) 
reported that the expressio n of cx-syn uc lei n in a 
megacaryocyte-platelet system is differentially regulated 
during megacaryocyte differentiation. 
To verify the possibility that the expression of cx-
synuclein homologue is differentially regulated during 
development, we in vestigated the temporal and spatial 
ex press ion pattern s of cx-syn uclein homologue in 
Drosophila embryos at di fferent developmental stages. The 
embryos were collected for 15 hand immunostained with 
affinity-purifi ed anti-a-synuclein antibod y. Immuno-
staining of the embryos showed that the synuclein was 
ex pressed across the whole embryo in early stage 2 
embryos (Fig. 4, panel 1) and showed the highest level of 
expression during development. At stage 5, synuclein was 
expressed evenly across the embryo but at somewhat lower 
level (Fig. 4, panel 2). At stage 7, synuclein was expressed 
higher at the anterior (cephalic funow) and posterior 30% 
region than in other parts of the embryo (Fig. 4, panel 3). 
At stage 10, the procephalon and dorsal regions showed a 
higher express ion of synuclein particularly at a region 
aro und clypeolabrum (Fig. 4, panel 4). At stage 13, 
synuclein showed higher expression in the procephalon 
and ventral nerve cord regions (Fig. 4 , panel 5). In 
summary, the protein was expressed ubiquitously and 
higher at early stages but the expression level decreased at 
later stages. As well, the protein was expressed slightly 
higher at the central nerve system (brain and nerve cord) in 
the later stages, which is in line with its function in the 
central nerve system. 
In this report, we showed that a-synuclein is expressed 
in hematopoietic cells including T cells, B cell s, NK ceJl s, 
and monocytes, as well as in the lymphoma cell lines, 
lurkat a nd K562 , sugges tin g that a-synuclein is 
ubiquitously expressed in hematopo ietic ce ll s . The 
ubiquitous expression of a-synuclein in hematopoietic 
cells could make it possible to design a diagnostic method 
for neurodegenerative diseases associated with the protein, 
and could make it convenient for detecting a genetic 
change in this protein. For example, the Ala to Ser change 
in familial Parkinsonism (Polymeropoulos et al., 1997) or 
abnormally processed forms of a-synuclein protein can be 
easily detected by DNA sequence analysis of RT-PCR 
products or immunostammg of proteins obtained from a 
blood sample. Further, we showed that the a-synuclein 
homologue is expressed in Drosophila , and that the 
expression of the protein appears to be temporally and 
spatially regulated during development. The protein was 
ubiquitously expressed in embryos at early stages of 
development, while it was highly expressed in brain and 
nerve cord of embryos at later stages. Taken together, our 
data s uggest th at a- synuclein may function in 
invertebrates, as well as in vertebrates, and that the 
functio n may not be restricted to the neuron. Particularly, 
the presence of the a-synuclein homologue in Drosophila 
will provide better opportuniti es for investigating the 
biological function of the protein through transgenic or 
knock-out studies . 
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